These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3392215)

  • 1. Use of vaccinia virus vectors to study protein processing in human disease. Normal nerve growth factor processing and secretion in cultured fibroblasts from patients with familial dysautonomia.
    Edwards RH; Rutter WJ
    J Clin Invest; 1988 Jul; 82(1):44-7. PubMed ID: 3392215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Processing and secretion of nerve growth factor: expression in mammalian cells with a vaccinia virus vector.
    Edwards RH; Selby MJ; Mobley WC; Weinrich SL; Hruby DE; Rutter WJ
    Mol Cell Biol; 1988 Jun; 8(6):2456-64. PubMed ID: 3405211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered nerve growth factor in fibroblasts from patients with familial dysautonomia.
    Schwartz JP; Breakefield XO
    Proc Natl Acad Sci U S A; 1980 Feb; 77(2):1154-8. PubMed ID: 6244581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural gene for beta-nerve growth factor not defective in familial dysautonomia.
    Breakefield XO; Orloff G; Castiglione C; Coussens L; Axelrod FB; Ullrich A
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4213-6. PubMed ID: 6330750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced neuronotrophic activity of fibroblasts from individuals with dysautonomia in cultures of newborn mouse sensory ganglion cells.
    Wrathall JR
    Brain Res; 1986 Jan; 364(1):23-9. PubMed ID: 3947964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of the native nerve growth factor precursor to form biologically active nerve growth factor.
    Edwards RH; Selby MJ; Garcia PD; Rutter WJ
    J Biol Chem; 1988 May; 263(14):6810-5. PubMed ID: 3360808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor.
    Fahnestock M; Yu G; Michalski B; Mathew S; Colquhoun A; Ross GM; Coughlin MD
    J Neurochem; 2004 May; 89(3):581-92. PubMed ID: 15086515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrograde nerve growth factor signaling abnormalities in familial dysautonomia.
    Li L; Gruner K; Tourtellotte WG
    J Clin Invest; 2020 May; 130(5):2478-2487. PubMed ID: 32281946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA polymorphisms for the nerve growth factor receptor gene exclude its role in familial dysautonomia.
    Breakefield XO; Ozelius L; Bothwell MA; Chao MV; Axelrod F; Kramer PL; Kidd KK; Lanahan AA; Johnson DE; Ross AH
    Mol Biol Med; 1986 Dec; 3(6):483-94. PubMed ID: 2886891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of the vaccinia virus expression system.
    Moss B; Earl PL
    Curr Protoc Mol Biol; 2002 Nov; Chapter 16():Unit16.15. PubMed ID: 18265301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor.
    Scott J; Selby M; Urdea M; Quiroga M; Bell GI; Rutter WJ
    Nature; 1983 Apr; 302(5908):538-40. PubMed ID: 6336309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes.
    Yaar M; Eller MS; DiBenedetto P; Reenstra WR; Zhai S; McQuaid T; Archambault M; Gilchrest BA
    J Clin Invest; 1994 Oct; 94(4):1550-62. PubMed ID: 7929831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro processing of the NGF precursors by the gamma-subunit of the 7S NGF complex.
    Jongstra-Bilen J; Coblentz L; Shooter EM
    Brain Res Mol Brain Res; 1989 Mar; 5(2):159-69. PubMed ID: 2716498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a beta-nerve growth factor expression vector for mammalian cells.
    Clegg DO
    Gene; 1993 Aug; 130(2):291-6. PubMed ID: 8395451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of vaccinia virus as a neuropeptide expression vector.
    Hruby DE; Thomas G; Herbert E; Franke CA
    Methods Enzymol; 1986; 124():295-309. PubMed ID: 3012250
    [No Abstract]   [Full Text] [Related]  

  • 16. Are there differences between the secretion characteristics of NGF and BDNF? Implications for the modulatory role of neurotrophins in activity-dependent neuronal plasticity.
    Griesbeck O; Canossa M; Campana G; Gärtner A; Hoener MC; Nawa H; Kolbeck R; Thoenen H
    Microsc Res Tech; 1999 May 15-Jun 1; 45(4-5):262-75. PubMed ID: 10383119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human neural stem cells genetically modified to express human nerve growth factor (NGF) gene restore cognition in the mouse with ibotenic acid-induced cognitive dysfunction.
    Lee HJ; Lim IJ; Park SW; Kim YB; Ko Y; Kim SU
    Cell Transplant; 2012; 21(11):2487-96. PubMed ID: 22526467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic neurons synthesize and secrete pro-nerve growth factor protein.
    Hasan W; Pedchenko T; Krizsan-Agbas D; Baum L; Smith PG
    J Neurobiol; 2003 Oct; 57(1):38-53. PubMed ID: 12973827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF.
    Strömberg I; Wetmore CJ; Ebendal T; Ernfors P; Persson H; Olson L
    J Neurosci Res; 1990 Mar; 25(3):405-11. PubMed ID: 2325166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential RNA splicing predicts two distinct nerve growth factor precursors.
    Edwards RH; Selby MJ; Rutter WJ
    Nature; 1986 Feb 27-Mar 5; 319(6056):784-7. PubMed ID: 2419763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.